Rapid Identification of Cell-Specific, Internalizing RNA Aptamers with Bioinformatics Analyses of a Cell-Based Aptamer Selection

Background The broad applicability of RNA aptamers as cell-specific delivery tools for therapeutic reagents depends on the ability to identify aptamer sequences that selectively access the cytoplasm of distinct cell types. Towards this end, we have developed a novel approach that combines a cell-based selection method (cell-internalization SELEX) with high-throughput sequencing (HTS) and bioinformatics analyses to rapidly identify cell-specific, internalization-competent RNA aptamers. Methodology/Principal Findings We demonstrate the utility of this approach by enriching for RNA aptamers capable of selective internalization into vascular smooth muscle cells (VSMCs). Several rounds of positive (VSMCs) and negative (endothelial cells; ECs) selection were performed to enrich for aptamer sequences that preferentially internalize into VSMCs. To identify candidate RNA aptamer sequences, HTS data from each round of selection were analyzed using bioinformatics methods: (1) metrics of selection enrichment; and (2) pairwise comparisons of sequence and structural similarity, termed edit and tree distance, respectively. Correlation analyses of experimentally validated aptamers or rounds revealed that the best cell-specific, internalizing aptamers are enriched as a result of the negative selection step performed against ECs. Conclusions and Significance We describe a novel approach that combines cell-internalization SELEX with HTS and bioinformatics analysis to identify cell-specific, cell-internalizing RNA aptamers. Our data highlight the importance of performing a pre-clear step against a non-target cell in order to select for cell-specific aptamers. We expect the extended use of this approach to enable the identification of aptamers to a multitude of different cell types, thereby facilitating the broad development of targeted cell therapies.

[1]  K Taira,et al.  Isolation and characterization of RNA aptamers specific for the hepatitis C virus nonstructural protein 3 protease. , 2000, European journal of biochemistry.

[2]  B. Sullenger,et al.  Simultaneous generation of aptamers to multiple gamma-carboxyglutamic acid proteins from a focused aptamer library using DeSELEX and convergent selection. , 2007, Oligonucleotides.

[3]  Andrea Rentmeister,et al.  Cell-Specific Aptamers as Emerging Therapeutics , 2011, Journal of nucleic acids.

[4]  L. Gold,et al.  Isolation of high-affinity RNA ligands to HIV-1 integrase from a random pool. , 1995, Virology.

[5]  Bertrand Tavitian,et al.  Neutralizing Aptamers from Whole-Cell SELEX Inhibit the RET Receptor Tyrosine Kinase , 2005, PLoS biology.

[6]  Weihong Tan,et al.  Identification of liver cancer-specific aptamers using whole live cells. , 2008, Analytical chemistry.

[7]  L. J. Maher,et al.  Selection and Characterization of an RNA Decoy for Transcription Factor NF-κB† , 1999 .

[8]  J Charlton,et al.  Highly potent irreversible inhibitors of neutrophil elastase generated by selection from a randomized DNA-valine phosphonate library. , 1997, Biochemistry.

[9]  H. U. Göringer,et al.  Combinatorial selection of high affinity RNA ligands to live African trypanosomes. , 1999, Nucleic acids research.

[10]  Ying-Fon Chang,et al.  Tenascin-C Aptamers Are Generated Using Tumor Cells and Purified Protein* , 2001, The Journal of Biological Chemistry.

[11]  Michael Zuker,et al.  Optimal computer folding of large RNA sequences using thermodynamics and auxiliary information , 1981, Nucleic Acids Res..

[12]  Walter Fontana,et al.  Fast folding and comparison of RNA secondary structures , 1994 .

[13]  D. S. Coffey,et al.  Identification and characterization of nuclease-stabilized RNA molecules that bind human prostate cancer cells via the prostate-specific membrane antigen. , 2002, Cancer research.

[14]  R. Landgraf,et al.  Inhibition of heregulin signaling by an aptamer that preferentially binds to the oligomeric form of human epidermal growth factor receptor-3 , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[15]  Yufei Huang,et al.  Mechanism of ribose 2'-group discrimination by an RNA polymerase. , 1997, Biochemistry.

[16]  M. Famulok,et al.  Discriminatory aptamer reveals serum response element transcription regulated by cytohesin-2. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[17]  L. Gold,et al.  A tenascin-C aptamer identified by tumor cell SELEX: Systematic evolution of ligands by exponential enrichment , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[18]  J. M. Healy,et al.  Complex Target SELEX , 2008 .

[19]  J. Szostak,et al.  In vitro selection of RNA molecules that bind specific ligands , 1990, Nature.

[20]  B. Sullenger,et al.  In vivo selection of tumor-targeting RNA motifs , 2009, Nature chemical biology.

[21]  William H. Thiel,et al.  Isolation and Optimization of Murine IL-10 Receptor Blocking Oligonucleotide Aptamers Using High-throughput Sequencing. , 2012, Molecular therapy : the journal of the American Society of Gene Therapy.

[22]  Gerhard Ziemer,et al.  CELL-SELEX: Novel Perspectives of Aptamer-Based Therapeutics , 2008, International journal of molecular sciences.

[23]  B. Sullenger,et al.  RNA aptamers as reversible antagonists of coagulation factor IXa , 2002, Nature.

[24]  L. Gold,et al.  Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. , 1990, Science.

[25]  L. Cerchia,et al.  Targeting cancer cells with nucleic acid aptamers. , 2010, Trends in biotechnology.

[26]  Paloma H. Giangrande,et al.  Delivery of chemo-sensitizing siRNAs to HER2+-breast cancer cells using RNA aptamers , 2012, Nucleic acids research.

[27]  James O McNamara,et al.  Targeted inhibition of αvβ3 integrin with an RNA aptamer impairs endothelial cell growth and survival , 2005 .

[28]  J. McNamara,et al.  Multivalent 4-1BB binding aptamers costimulate CD8+ T cells and inhibit tumor growth in mice. , 2008, The Journal of clinical investigation.

[29]  J. Nevins,et al.  Distinct roles of E2F proteins in vascular smooth muscle cell proliferation and intimal hyperplasia , 2007, Proceedings of the National Academy of Sciences.

[30]  S. Barth,et al.  Cell-specific induction of apoptosis by rationally designed bivalent aptamer-siRNA transcripts silencing eukaryotic elongation factor 2. , 2008, Current cancer drug targets.

[31]  Peter F. Stadler,et al.  ViennaRNA Package 2.0 , 2011, Algorithms for Molecular Biology.

[32]  R. Sousa,et al.  A mutant T7 RNA polymerase as a DNA polymerase. , 1995, The EMBO journal.

[33]  A. Barclay,et al.  Cutting edge: novel RNA ligands able to bind CD4 antigen and inhibit CD4+ T lymphocyte function. , 1998, Journal of immunology.

[34]  James O McNamara,et al.  Nucleotide bias observed with a short SELEX RNA aptamer library. , 2011, Nucleic acid therapeutics.

[35]  L. J. Maher,et al.  Selection and characterization of an RNA decoy for transcription factor NF-kappa B. , 1999, Biochemistry.

[36]  A D Ellington,et al.  Selection and design of high-affinity RNA ligands for HIV-1 Rev. , 1993, Gene.

[37]  L. Gold,et al.  High affinity ligands from in vitro selection: complex targets. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[38]  H. Schluesener,et al.  Systematic Evolution of a DNA Aptamer Binding to Rat Brain Tumor Microvessels , 2001, The Journal of Biological Chemistry.

[39]  J. McCaskill The equilibrium partition function and base pair binding probabilities for RNA secondary structure , 1990, Biopolymers.

[40]  C H Heldin,et al.  Inhibitory DNA ligands to platelet-derived growth factor B-chain. , 1996, Biochemistry.

[41]  Li Li,et al.  Label-free aptamer-based colorimetric detection of mercury ions in aqueous media using unmodified gold nanoparticles as colorimetric probe , 2009, Analytical and bioanalytical chemistry.

[42]  B. Tavitian,et al.  Differential SELEX in Human Glioma Cell Lines , 2009, PloS one.

[43]  Doris Chen,et al.  Monitoring Genomic Sequences during SELEX Using High-Throughput Sequencing: Neutral SELEX , 2010, PloS one.

[44]  T. Böhm,et al.  Controlling small guanine–nucleotide-exchange factor function through cytoplasmic RNA intramers , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[45]  J. McNamara,et al.  Degradation of nuclease-stabilized RNA oligonucleotides in Mycoplasma-contaminated cell culture media. , 2012, Nucleic acid therapeutics.

[46]  Weihong Tan,et al.  Selection of DNA ligands for protein kinase C-delta. , 2006, Chemical communications.

[47]  Seung Soo Oh,et al.  Quantitative selection of DNA aptamers through microfluidic selection and high-throughput sequencing , 2010, Proceedings of the National Academy of Sciences.

[48]  P. Giangrande,et al.  Therapeutic applications of DNA and RNA aptamers. , 2009, Oligonucleotides.

[49]  Hui Chen,et al.  Molecular recognition of acute myeloid leukemia using aptamers , 2008, Leukemia.

[50]  J. McNamara,et al.  Targeted inhibition of alphavbeta3 integrin with an RNA aptamer impairs endothelial cell growth and survival. , 2005, Biochemical and biophysical research communications.

[51]  J. McNamara,et al.  Rational truncation of an RNA aptamer to prostate-specific membrane antigen using computational structural modeling. , 2011, Nucleic acid therapeutics.

[52]  Yi Xiao,et al.  Probing the Limits of Aptamer Affinity with a Microfluidic SELEX Platform , 2011, PloS one.

[53]  Siamon Gordon,et al.  Neutralization of Infectivity of Diverse R5 Clinical Isolates of Human Immunodeficiency Virus Type 1 by gp120-Binding 2′F-RNA Aptamers , 2003, Journal of Virology.

[54]  Rolf Backofen,et al.  Variations on RNA folding and alignment: lessons from Benasque , 2007, Journal of mathematical biology.

[55]  B. Sullenger,et al.  RNA aptamer blockade of osteopontin inhibits growth and metastasis of MDA-MB231 breast cancer cells. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

[56]  Sheela M. Waugh,et al.  2′-Fluoropyrimidine RNA-based Aptamers to the 165-Amino Acid Form of Vascular Endothelial Growth Factor (VEGF165) , 1998, The Journal of Biological Chemistry.

[57]  Martin Vingron,et al.  A calibrated diversity assay for nucleic acid libraries using DiStRO—a Diversity Standard of Random Oligonucleotides , 2009, Nucleic acids research.

[58]  L. Gold,et al.  RNA ligands to human nerve growth factor. , 1995, Nucleic acids research.

[59]  S. Watson,et al.  Isolation and characterization of 2'-fluoro-, 2'-amino-, and 2'-fluoro-/amino-modified RNA ligands to human IFN-gamma that inhibit receptor binding. , 1997, Journal of immunology.

[60]  E. Vermaas,et al.  Selection of single-stranded DNA molecules that bind and inhibit human thrombin , 1992, Nature.

[61]  W. Wetsel,et al.  Targeting inhibition of GluR1 Ser845 phosphorylation with an RNA aptamer that blocks AMPA receptor trafficking , 2009, Journal of neurochemistry.

[62]  N. Janjić,et al.  High-affinity RNA ligands to basic fibroblast growth factor inhibit receptor binding. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[63]  F. Luo,et al.  Aptamer from whole-bacterium SELEX as new therapeutic reagent against virulent Mycobacterium tuberculosis. , 2007, Biochemical and biophysical research communications.

[64]  Zoltán Konthur,et al.  Probing the SELEX Process with Next-Generation Sequencing , 2011, PloS one.

[65]  J. Nevins,et al.  Optimizing aptamer activity for gene therapy applications using expression cassette SELEX. , 2002, Molecular therapy : the journal of the American Society of Gene Therapy.